Lamotrigine-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and amniotic membranes

Archives of Dermatology

Volumn 144, Issue 6, 2008, Pages 724-726

  Schwartz, Rodrigo ^a,b,c   Avello, Esteban ^b   Palisson, Francis ^b  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXCHLORPHENIRAMINE MALEATE; IMMUNOGLOBULIN; LAMOTRIGINE; SODIUM DIHYDROGEN PHOSPHATE;

ADULT; AMNION; ARTICLE; ASSAULT; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CHINESE; CLINICAL FEATURE; DEPRESSION; DRUG DOSE INCREASE; EMERGENCY WARD; FEMALE; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LABORATORY TEST; PRIORITY JOURNAL; RASH; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; BIOLOGICAL DRESSINGS; BIPOLAR DISORDER; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; TRIAZINES;

EID: 45349107278     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.6.724     Document Type: Article

References (20)

1. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis. N Engl J Med. 1995;333(24):1600-1609.
2. Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol. 1996;134(4):710-714.
3. Troensegaard-Hansen E. Amniotic grafts in chronic skin ulceration. Lancet. 1950;1(6610):859-860.
4. Mermet I, Pottier N, Sainthillier JM, et al. Use of amniotic membrane transplantation in the treatment of venous leg ulcers. Wound Repair Regen. 2007;15(4):459-464.
5. Singh R, Chouhan US, Purohit S, et al. Radiation processed amniotic membranes in the treatment of non-healing ulcers of different etiologies. Cell Tissue Bank. 2004;5(2):129-134.
6. Robson MC, Krizek TJ. The effect of human amniotic membranes on the bacteria population of infected rat burns. Ann Surg. 1973;177(2):144-149.
7. Bose B. Burn wound dressing with human amniotic membrane. Ann R Coll Surg Engl. 1979;61(6):444-447.
8. Rao TV, Chandrasekharam V. Use of dry human and bovine amnion as a biological dressing. Arch Surg. 1981;116(7):891-896.
9. Branski LK, Herndon DN, Celis MM, Norbury WB, Masters OE, Jeschke MG. Amnion in the treatment of pediatric partial-thickness facial burns [published online October 24, 2007]. Burns. 2008;34(3):393-399. doi:10.1016/j.burns. 2007.06.007.
10. Waikakul S, Chumniprasas K, Setasubun S, Vajaradul Y. Application of freeze-dried amniotic membrane: a control trial at the donor site of split-thickness skin grafting. Bull Hosp Jt Dis Orthop Inst. 1990;50(1):27-34.
11. Martínez Pardo ME, Reyes Frias ML, Ramos Duron LE, et al. Clinical application of amniotic membranes on a patient with epidermolysis bullosa. Ann Transplant. 1999;4(3-4):68-73.
12. Subrahmanyam M. Amniotic membrane as a cover or microskin grafts. Br J Plast Surg. 1995;48(7):477-478.
13. Rejzek A, Weyer F, Eichberger R, Gebhart W. Physical changes of amniotic membranes through glycerolisation for the use as an epidermal substitute: light and electron microscope studies. Cell Tissue Bank. 2001;2(2):95-102.
14. Prasad JK, Feller I, Thomson PD. Use of amnion for the treatment of Stevens-Johnson syndrome. J Trauma. 1986;26(10):945-946.
15. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282(5388):490-493.
16. Coassin M, Lambiase A, Micera A, Tirassa P, Aloe L, Bonini S. Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane [published online September 13, 2005]. Graefes Arch Clin Exp Ophthalmol. 2006;244(4):485-491.
17. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20(3):173-177.
18. Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005;35(7):941-948.
19. Li W, He H, Kawakita T, Espana EM, Tseng SC. Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro [published online August 16, 2005]. Exp Eye Res. 2006;82(2):282-292.
20. Ramakrishnan KM, Jayaraman V. Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns. 1997;23(suppl 1):S33-S36.